Glucograv S
Sitagliptin + Metformin
Type 2 diabetes inadequately controlled on metformin alone; dual-mechanism glycaemic control.
Each film-coated tablet contains Sitagliptin Phosphate Monohydrate equivalent to Sitagliptin and Metformin Hydrochloride IP.
Sequential granulation with segregated API addition to guarantee content uniformity of the low-dose component.
This information is intended for healthcare professionals and trade partners. The brand name applies to Graviti's own branded generics range in India; in other markets the same formulation is supplied as a generic under our filings or a partner label. Prescribing information, registration status and pack availability vary by market. Medicines should be used only under qualified medical supervision.
Glucograv S — made to the same standard as every Graviti batch.